Creatine for the Brain: Does Creatine Improve Memory and Cognition?

Creatine is one of the most studied supplements in sports nutrition, but a growing body of research asks a different question: does creatine do anything for the brain? The brain is an energetically expensive organ, and the same molecule that helps muscle cells recycle ATP may matter for neurons too. This article reviews what the human evidence actually shows about creatine and memory, cognition, attention, mental fatigue, sleep deprivation and cognitive aging — and, just as importantly, what it does not show.

This is an evidence review, not a product guide. For creatine forms, label-reading, powder-versus-capsules, and serving-size questions, see the related HerbParlor resources linked at the end.

What Does Creatine Do in the Brain?

Inside cells, creatine is converted to phosphocreatine, which acts as a rapid buffer and shuttle for high-energy phosphate groups. When energy demand spikes, phosphocreatine helps regenerate ATP — the cell's immediate energy currency — faster than ATP can be made from scratch. This creatine–phosphocreatine system is prominent in tissues with high, fluctuating energy demands, including skeletal muscle, the heart, and the brain.

The brain consumes a disproportionate share of the body's energy relative to its weight, and neurons rely on tightly regulated ATP to fire, signal, and maintain ion gradients. Some creatine is synthesised endogenously, and some is obtained from the diet (particularly from meat and fish). Brain creatine levels can also be influenced by supplementation, which is the mechanistic basis for the cognitive research reviewed below.

The central mechanistic idea is simple: if neural energy buffering matters for performance under stress or fatigue, then increasing brain creatine availability might help the brain maintain output when demand is high. Whether that plausible mechanism translates into measurable cognitive benefits in healthy adults is a separate, empirical question — and the evidence is mixed.

Does Creatine Improve Memory?

Memory is the cognitive outcome most often discussed in connection with creatine. A 2024 systematic review and meta-analysis by Xu and colleagues (PMID 39070254) pooled the available adult trials and reported a positive signal for memory outcomes among the studies that measured them. That is a meaningful finding: across the combined evidence, memory performance tended to be better with creatine than with control.

However, that signal should be read carefully. The memory effect was not uniform across every test or population, the underlying trials varied in design, dose, duration and the specific memory tasks used, and the certainty of the evidence differed across outcomes. A positive pooled signal is not the same as a guaranteed benefit for any individual. It is best understood as "the literature points in a positive direction for memory, with caveats."

It is also worth noting that not every review reaches the same emphasis. A 2024 systematic review by McMorris and colleagues (PMID 38582412) argued that the existing creatine-and-cognition research fails to support the theoretical basis for a cognitive effect, highlighting methodological weaknesses and inconsistent findings. A 2026 commentary by Citherlet (PMID 42039906) on the Xu meta-analysis further discussed methodological considerations affecting the interpretation of the pooled cognitive findings; such commentary underscores the need for caution when interpreting the pooled estimates, but it does not by itself prove that the meta-analysis is invalid or that its memory signal is wrong. Taken together, the memory evidence is suggestive rather than settled.

Does Creatine Improve Cognition?

"Cognition" is a broad umbrella, and this is where the evidence becomes notably more cautious. In the 2024 Xu meta-analysis (PMID 39070254), the pooled analysis did not show a statistically significant improvement in overall cognition when cognitive outcomes were considered together. In other words, while individual domains such as memory pointed one way, the broader composite measure of cognition did not.

This distinction matters. A supplement can show a signal in one cognitive domain while showing no significant effect on an aggregate cognition score, because the aggregate blends domains that move in different directions or that are measured too variably to detect a difference. The absence of a significant overall-cognition result is therefore not a contradiction of the memory signal — it is a statement about a different, noisier outcome. The same meta-analysis also did not show a significant effect on executive function.

The practical reading: the evidence does not support a blanket claim that creatine "improves cognition" in the general sense. It supports a more specific, qualified discussion of particular domains measured under particular conditions.

Does Creatine Improve Focus and Attention?

Attention is another domain where the 2024 meta-analysis (PMID 39070254) reported a directional signal. Specifically, the analysis pointed to a positive signal for measures of attention time — the speed component of attention tasks — among the studies that assessed it.

That is a narrower finding than "creatine improves focus" in everyday language. Attention time on a laboratory task is not the same as the subjective feeling of being focused during a workday, and the trials were short-term, varied, and conducted in different populations. The signal is worth noting, but it does not justify a claim that creatine universally improves focus or concentration.

Does Creatine Help With Mental Fatigue?

Mental fatigue is where the creatine–energy-buffering mechanism is most theoretically compelling. When the brain is pushed hard over time, neural energy demand rises, and an intervention that supports ATP buffering might plausibly help sustain performance.

Some individual trials have reported that creatine supplementation appeared to help maintain cognitive performance during prolonged or demanding mental tasks, and the attention-time and processing-speed signals in the 2024 meta-analysis (PMID 39070254) are consistent with that idea. But the evidence base for mental fatigue specifically is limited and heterogeneous: studies use different fatigue-inducing protocols, different outcomes, and different populations, which makes it hard to draw a firm, generalisable conclusion.

The honest summary is that mental fatigue is a plausible and partially supported target, but the research is not yet strong or consistent enough to treat as established.

What Does the Research Show During Sleep Deprivation?

Sleep deprivation is a useful natural experiment for the energy-buffering hypothesis, because it acutely stresses the systems that maintain alertness and cognitive performance.

A 2026 systematic review by Williams and colleagues (PMID 42261581) examined creatine supplementation and acute sleep deprivation, covering cognitive, psychomotor and mood outcomes. Importantly, that review identified only five eligible studies — a small evidence base. Within that limited set, the authors described an early positive trend for some cognitive and psychomotor outcomes, but the trend is preliminary precisely because so few studies met the inclusion criteria.

Separately, a 2026 randomized controlled trial (PMID 42075005) directly tested creatine supplementation during acute sleep deprivation and assessed cognitive and psychomotor outcomes. This individual trial is distinct from the systematic review above: it is a single primary study rather than a pooled synthesis, so its findings should be read on their own terms and not conflated with the review's broader (but still small) trend. Together, the review and the trial point in a cautiously encouraging direction, but neither is conclusive.

It is critical not to overstate this. A preliminary positive trend in five studies, and a single randomized trial, do not mean creatine replaces sleep, offsets the need for rest, or reliably rescues performance after sleep loss. Sleep remains essential, and no supplement is a substitute for adequate sleep. The sleep-deprivation findings are best read as an early, hypothesis-supporting signal that warrants larger and more rigorous trials.

Does Creatine Work for Older Adults?

Older adults are a population of particular interest, because brain creatine levels and energetic capacity can change with age, and because cognitive aging is a major public-health concern.

A February 2026 systematic review by Marshall and colleagues (PMID 40971619) examined creatine and cognition in aging and reported a generally positive association across the studies it included — that is, the reviewed studies tended to favour creatine on cognitive outcomes in older adults. However, that evidence should be considered limited: the underlying studies were few and heterogeneous, so the review represents an early signal rather than a definitive verdict.

That limited status is reinforced by subsequent critique. In October 2026, a methodological commentary (PMID 41405942) questioned aspects of how the older-adult evidence had been synthesised and interpreted, flagging concerns about the review's methods and the strength of its conclusions. The original authors responded to that commentary the same month (PMID 41405448), addressing the criticisms and clarifying their position. The existence of this exchange — criticism followed by author response — is itself a signal that the older-adult evidence is still actively contested and should not be presented as settled.

A 2026 review/commentary (PMID 41405444) further addressed methodological limitations across the creatine-and-cognition literature, and a 2026 scoping review (PMID 42668123) examined creatine, older adults and dementia-related cognitive outcomes. Together, these later publications make clear that the older-adult evidence is still developing and that its interpretation is contested.

A 2026 randomized trial by Chun and colleagues (PMID 42578920) examined the effects of creatine supplementation, with and without a combined exercise and diet intervention, on body composition, cognitive function, and markers of health in middle-aged and older adults. The cognitive outcomes in that trial were exploratory, so any cognitive observations should be read as hypothesis-generating rather than confirmatory, and they do not establish a cognitive benefit on their own.

The balanced position: the February review pointed in a positive direction, but the evidence is limited, and subsequent methodological criticism (with the authors' response) has flagged caveats, so the older-adult findings should be treated as promising but not yet conclusive.

Does Creatine Cross the Blood-Brain Barrier?

A reasonable mechanistic question is whether supplemented creatine even reaches the brain. Creatine is not thought to cross the blood-brain barrier freely by simple passive diffusion; instead, the brain expresses specific creatine transporters that can take up creatine from the circulation, and the brain also synthesises creatine endogenously.

Human neuroimaging studies (using magnetic resonance spectroscopy) have reported measurable increases in brain creatine signals following supplementation in some populations, which is consistent with the idea that dietary/supplemental creatine can influence brain creatine content under at least some conditions. The magnitude and reliability of these changes can vary, and transporter saturation, baseline status, and diet (for example, vegetarian versus omnivorous intake) may all play a role.

The takeaway is that "does creatine cross into the brain?" is not a simple yes/no: the brain has regulated routes by which creatine availability can be influenced, which is why the cognitive research is mechanistically plausible in the first place.

Does Creatine Help Vegetarians and Vegans?

Because dietary creatine comes mainly from animal products, vegetarians and vegans typically have lower baseline creatine intake and, in some studies, lower tissue creatine levels than omnivores. This makes them a population where supplementation might, in principle, produce a larger relative change.

Some trials in vegetarians have reported cognitive changes consistent with the broader literature — directional signals on tasks involving memory or processing — but the number of studies is small and the evidence is not conclusive. The mechanistic logic (lower baseline, more room to increase) is sound, but it should not be converted into a guarantee of benefit. Vegetarians and vegans are a plausible candidate population for larger, better-designed trials rather than a group for whom benefits are already proven.

Is Creatine a Nootropic?

"Nootropic" is a marketing term more than a scientific one, and there is no agreed clinical definition. Whether creatine "counts" depends on what one means by the word.

If "nootropic" means "a substance with a plausible neural mechanism and some positive signals in specific cognitive domains under specific conditions," then creatine is a reasonable candidate — it has a clear energy-buffering mechanism, a positive memory signal, an attention-time signal, and a processing-speed signal in the 2024 meta-analysis (PMID 39070254). If "nootropic" means "a substance that reliably makes healthy people smarter or more focused in general," then the evidence does not support that claim for creatine, because the overall-cognition result was not significant and the effects are domain-specific and conditional.

The clearest answer is that creatine is a well-studied ergogenic aid with a mechanistically plausible and partially supported role in certain cognitive contexts — not a general-purpose cognitive enhancer.

Creatine Compared With Other Cognitive Supplements

Readers often ask how creatine compares with other supplements marketed for cognition, such as omega-3 fatty acids, B vitamins, caffeine, or herbal nootropics. This article does not rank supplements or declare a winner, and for good reason.

Direct comparisons between cognitive supplements are difficult because the relevant studies differ in almost every dimension that matters: the population studied (young adults, older adults, vegetarians, sleep-deprived individuals), the intervention (dose, form, duration), the control condition, the cognitive domains measured, the tests used, and the statistical approach. A supplement that looks favourable in one trial design may look neutral in another, and head-to-head trials of cognitive supplements are rare.

Because of this heterogeneity, comparing effect sizes across separate reviews is not like-for-like. The more useful question is not "which supplement is best for the brain?" but "for a given population and a given cognitive demand, what does the evidence support?" Creatine's evidence sits in that context-specific frame, alongside — not in competition with — the evidence for other compounds.

How Strong Is the Evidence?

The table below summarises the direction and strength of the current human evidence, distinguishing a positive signal from a settled finding. "Signal" means a directional trend in the pooled or reviewed literature; "no significant effect" means the pooled analysis did not reach significance for that outcome; and "preliminary" means the evidence base is too small to be conclusive.

Outcome	Direction of evidence	Evidence strength / limitations
Memory	Positive signal	Reported in the 2024 Xu meta-analysis (PMID 39070254); certainty varies across memory tasks and populations; not uniform. A 2026 commentary (Citherlet, PMID 42039906) discussed methodological considerations in interpreting the pooled findings.
Attention (attention time)	Positive signal	Directional signal for attention-time measures in the 2024 meta-analysis (PMID 39070254); narrow laboratory measure, not everyday "focus."
Processing speed	Positive signal	Reported in the 2024 meta-analysis (PMID 39070254); based on a limited and heterogeneous set of trials.
Overall cognition (composite)	No significant effect	The 2024 meta-analysis (PMID 39070254) did not show a significant improvement in the aggregate cognition outcome.
Executive function	No significant effect	The 2024 meta-analysis (PMID 39070254) did not show a significant executive-function result.
Sleep deprivation	Preliminary positive trend	2026 Williams systematic review (PMID 42261581) included only five eligible studies; a 2026 randomized trial (PMID 42075005) provides a single primary data point. Trend is early and not conclusive; does not replace sleep.
Older adults	Limited positive association, contested	February 2026 Marshall review (PMID 40971619) reported a generally positive association but is limited evidence; October 2026 methodological commentary (PMID 41405942) and the authors' response (PMID 41405448) show the interpretation is contested. A 2026 randomized trial (Chun, PMID 42578920) reported exploratory cognitive outcomes only. Not definitive.
Dementia / cognitive impairment	Insufficient human evidence	Preclinical rationale exists; human prevention/treatment evidence is lacking. A 2026 scoping review (PMID 42668123) covers older adults and dementia-related cognitive outcomes. No prevention or treatment claims are supported.

The certainty of the evidence differs across these outcomes, and that is the most important point: a positive signal in one domain does not generalise to all of cognition, and a preliminary trend in a small literature is not the same as an established effect.

What the Research Does NOT Show

It is as important to state the boundaries of the evidence as to describe the signals. The current literature does not show that creatine:

• makes everyone smarter — there is no significant overall-cognition effect, and individual responses vary;
• universally improves focus — the attention signal is specific to attention-time measures, not a general focus benefit;
• prevents dementia — there is no human evidence that creatine prevents dementia or cognitive decline at a population level;
• treats Alzheimer's disease — creatine is not an approved or established treatment for Alzheimer's or any other neurodegenerative disease;
• replaces sleep — the sleep-deprivation evidence is preliminary and based on five studies plus a single randomized trial; sleep remains essential and irreplaceable;
• guarantees cognitive benefits — effects, where present, are domain-specific, conditional, and of varying certainty.

Distinguishing evidence from speculation is the whole point of this review. The mechanistic plausibility of creatine in the brain is not, by itself, proof of benefit; and a positive signal in a meta-analysis is not a guarantee of an individual outcome.

What Researchers Still Need to Know

The literature has clear gaps. Larger, well-controlled trials are needed that:

• pre-specify cognitive domains and use consistent, validated test batteries rather than heterogeneous ad-hoc tasks;
• report individual-level response variability, not just group means;
• clarify dose, form, and duration relationships for cognitive (as opposed to muscular) outcomes;
• examine candidate populations — older adults, vegetarians and vegans, and sleep-deprived individuals — with adequate power;
• disentangle acute energy-buffering effects from any longer-term effects on cognitive aging;
• move carefully from preclinical dementia models to rigorous human studies without overinterpreting early signals.

The 2026 commentaries and scoping reviews underscore that methodological rigour — in outcome selection, blinding, control conditions, and synthesis — is the limiting factor right now, more than the number of studies alone.

Bottom Line

Creatine has a credible neural mechanism: it supports the rapid recycling of cellular energy, and the brain is an energetically demanding organ. The human evidence is partial and conditional. The 2024 meta-analysis (PMID 39070254) reported positive signals for memory, attention time and processing speed, but no significant effect on overall cognition or executive function, with varying certainty across outcomes. A 2024 systematic review (PMID 38582412) remained sceptical of the theoretical basis for a cognitive effect, and a 2026 commentary on the meta-analysis (PMID 42039906) discussed methodological considerations in interpreting its pooled findings. The 2026 older-adult literature (PMID 40971619) pointed in a generally positive direction but is limited evidence, and was subsequently the subject of methodological criticism (PMID 41405942) and an authors' response (PMID 41405448); a 2026 randomized trial in middle-aged and older adults (PMID 42578920) reported only exploratory cognitive outcomes. The 2026 sleep-deprivation review (PMID 42261581) — based on only five studies — and a 2026 randomized trial (PMID 42075005) described a preliminary trend that does not make creatine a substitute for sleep.

The honest conclusion is that creatine is a plausible, partially supported candidate for specific cognitive contexts — particularly domains involving memory, attention time and processing speed, and conditions of energetic stress — but it is not a general cognitive enhancer, not a dementia preventive, and not a sleep replacement. Anyone considering creatine for cognitive reasons should weigh the qualified evidence, avoid extrapolating beyond it, and consult a qualified healthcare professional, especially if managing a medical condition.